株探米国株
日本語 英語
エドガーで原本を確認する
false 0001113232 0001113232 2025-11-04 2025-11-04 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): November 4, 2025

 

Axcelis Technologies, Inc.

(Exact name of registrant as specified in its charter)

 

Delaware   000-30941   34-1818596
(State or other jurisdiction   (Commission   (IRS Employer
of incorporation)   File Number)   Identification No.)

 

108 Cherry Hill Drive, Beverly, Massachusetts   01915
(Address of principal executive offices)   (Zip Code)

 

Registrant’s telephone number, including area code: (978) 787-4000

 

(Former name or former address, if changed since last report.)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2.):

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ¨

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class Trading Symbol(s) Name of each exchange on which registered
Common Stock, par value $0.001 per share ACLS NASDAQ Global Select Market

 

 

 


 

Item 2.02 Results of Operations and Financial Condition

 

On November 4, 2025, Axcelis Technologies, Inc. (the “Company”) issued a press release regarding its financial results for its quarter ended September 30, 2025. The Company’s press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and incorporated by reference herein.

 

Item 9.01 Financial Statements and Exhibits.

 

Exhibit No.   Description
     
99.1   Press Release dated November 4, 2025. Filed herewith
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

2


 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: November 4, 2025 Axcelis Technologies, Inc.
   
  By: /s/ James Coogan
    James Coogan
    Executive Vice President and Chief Financial Officer

 

3 

 

EX-99.1 2 tm2530071d1_ex99-1.htm EXHIBIT 99.1

Exhibit 99.1

 

News Release  

 

Axcelis Announces Financial Results for Third Quarter 2025

 

Q3 Highlights:

 

Revenue of $213.6 million
GAAP Gross Margin of 41.6%, and Non-GAAP Gross Margin of 41.8%
GAAP Operating Margin of 11.7% and Non-GAAP Operating Margin of 18.2%
GAAP Diluted earnings per share of $0.83, and Non-GAAP Diluted earnings per share of $1.21

 

BEVERLY, Mass.— November 4, 2025—Axcelis Technologies, Inc. (Nasdaq: ACLS) today announced financial results for the third quarter ended September 30, 2025.

 

President and CEO Russell Low commented, “We delivered another solid quarter, with sales and earnings both exceeding our expectations. We are also pleased to report record CS&I revenue in the quarter, reflecting the success of our aftermarket strategy and the continued expansion of our installed base. We are executing on our product development roadmap and customer engagement initiatives with focus and urgency, while maintaining disciplined cost controls. These actions have enabled us to successfully navigate the anticipated cyclical digestion period across our markets in 2025.”

 

Low added, “We entered the fourth quarter with a solid financial foundation and are well poised to execute on our strategy as we enter into our next chapter of growth and innovation. Our recently announced merger with Veeco Instruments marks a critical milestone that we believe will position the combined company to capitalize on powerful secular tailwinds including AI and electrification. By bringing our two companies together, we believe we are building a leading semiconductor equipment company with the capabilities, resources and financial foundation to drive sustainable growth and value creation for shareholders and deliver meaningful benefits to all stakeholders.”

 

Executive Vice President and Chief Financial Officer Jamie Coogan stated, “We generated robust operating leverage through higher volume and disciplined cost management, translating into strong free cash flow. With over $590 million in cash and investments on the balance sheet, Axcelis has ample flexibility to capitalize on our value-enhancing strategic initiatives and long-term growth priorities.”

 

 


 

News Release  

 

Results Summary

(In thousands, except per share amounts and percentages)

 

    Three months ended September 30,  
    2025     2024  
Revenue   $ 213,611     $ 256,564  
Gross margin     41.6 %     42.9 %
Operating margin     11.7 %     18.3 %
Net income   $ 25,986     $ 48,576  
Diluted earnings per share   $ 0.83     $ 1.49  
Non-GAAP Results                
Non-GAAP gross margin     41.8 %     43.0 %
Non-GAAP operating margin     18.2 %     21.7 %
Adjusted EBITDA   $ 43,202     $ 59,674  
Non-GAAP net income   $ 37,900     $ 56,191  
Non-GAAP diluted earnings per share   $ 1.21     $ 1.72  

 

Business Outlook

 

For the fourth quarter ending December 31, 2025, Axcelis expects revenues of approximately $215 million, GAAP earnings per diluted share of approximately $0.76, and non-GAAP earnings per share of approximately $1.12.

 

Please refer to Fourth Quarter Outlook under the “Notes on our Non-GAAP Financial Information” section of this document for detail relating to the computation of non-GAAP earnings per diluted share as well as the Safe Harbor Statement section of this document.

 

Third Quarter 2025 Conference Call

 

The Company will host a call today to discuss the results at 8:30 a.m. ET. The call will be available via webcast that can be accessed through the Investors page of Axcelis' website at www.axcelis.com, or by registering as a participant here: https://register-conf.media-server.com/register/BI7b3b54c06ff14c8080f379ce76dc7cab Webcast replays will be available for 30 days following the call.

 

Use of Non-GAAP Financial Results

 

This press release includes financial measures that are not presented in accordance with U.S. generally accepted accounting principles (“non-GAAP financial measures”). These non-GAAP financial measures include non-GAAP gross profit, non-GAAP gross margin, non-GAAP operating income, non-GAAP operating margin, non-GAAP income tax provision, Adjusted EBITDA, non-GAAP net income, and non-GAAP diluted earnings per share, and reflect adjustments for the impact of share-based compensation expense, certain items related to restructuring and severance charges and any associated adjustments and transaction and integration costs associated with the merger agreement with Veeco Instruments announced on October 1, 2025.

 

 


 

News Release  

 

Reconciliations of these non-GAAP financial measures to the most directly comparable financial measures calculated and presented in accordance with GAAP are provided in the financial tables included in this release.

 

For further information regarding these non-GAAP financial measures, please refer to the tables presenting reconciliations of our non-GAAP results to our GAAP results and the “Notes on Our Non-GAAP Financial Information” at the end of this press release.

 

Safe Harbor Statement

 

This press release contains, and the conference call will contain, forward-looking statements under the Private Securities Litigation Reform Act safe harbor provisions. These statements, which include our expectations for spending in our industry and guidance for future financial performance, are based on management’s current expectations and should be viewed with caution. They are subject to various risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements, many of which are outside the control of the Company, including that customer decisions to place orders or our product shipments may not occur when we expect, that orders may not be converted to revenue in any particular quarter, or at all, whether demand will continue for the semiconductor equipment we produce or, if not, whether we can successfully meet changing market requirements, and whether we will be able to maintain continuity of business relationships with and purchases by major customers and, with respect to the potential transaction with Veeco, failure to obtain applicable regulatory or stockholder approvals in a timely manner or otherwise; failure to satisfy other closing conditions to the proposed transaction or to complete the proposed transaction on anticipated terms and timing; negative effects of the announcement of the proposed transaction; risks that the businesses will not be integrated successfully or that the combined company will not realize expected benefits, cost savings, accretion, synergies and/or growth, or that such benefits may take longer to realize or may be more costly to achieve than expected; the risk that disruptions from the proposed transaction will harm business plans and operations; risks relating to unanticipated costs of integration; significant transaction and/or integration costs, or difficulties in connection with the proposed transaction and/or unknown or inestimable liabilities; restrictions during the pendency of the proposed transaction that may impact the ability to pursue certain business opportunities or strategic transactions; potential litigation associated with the proposed transaction; the potential impact of the announcement or consummation of the proposed transaction on the Company’s, Veeco’s or the combined company’s relationships with suppliers, customers, employees and regulators; and demand for the combined company’s products. Actual results may differ materially from those projected in such statements due to various factors, including but not limited to: economic, political and social conditions in the countries in which the Company and Veeco, their respective customers and suppliers operate; disruption to the Company’s and Veeco’s respective manufacturing facilities or other operations, or the operations of Company’s and Veeco’s respective customers and suppliers, due to natural catastrophic events, health epidemics or terrorism; ongoing changes in the technology industry, and the semiconductor industry in particular, including future growth rates, pricing trends in end-markets, or changes in customer capital spending patterns; the Company’s, Veeco’s and the combined company’s ability to timely develop new technologies and products that successfully anticipate or address changes in the semiconductor industry; the Company’s, Veeco’s and the combined company’s ability to maintain their respective technology advantage and protect their respective proprietary rights; the Company’s, Veeco’s and the combined company’s ability to compete with new products introduced by their respective competitors; the Company’s, Veeco’s and the combined company’s ability or the ability of their respective customers to obtain U.S. export control licenses for the sale of certain products or provision of certain services to customers in China. Increased competitive pressure on sales and pricing, increases in material and other production costs that cannot be recouped in product pricing and instability caused by changing global economic, political or financial conditions, including with respect to the imposition of tariffs on our products or components of our products, could also cause actual results to differ materially from those in our forward-looking statements. These risks and other risk factors relating to Axcelis are described more fully in the most recent Form 10-K filed by Axcelis and in other documents filed from time to time with the Securities and Exchange Commission.

 

 


 

News Release  

 

About Axcelis:

 

Axcelis (Nasdaq: ACLS), headquartered in Beverly, Mass., has been providing innovative, high-productivity solutions for the semiconductor industry for over 45 years. Axcelis is dedicated to developing enabling process applications through the design, manufacture and complete life cycle support of ion implantation systems, one of the most critical and enabling steps in the IC manufacturing process. Learn more about Axcelis at www.axcelis.com.

 

CONTACTS:

 

Investor Relations Contact:

David Ryzhik

Senior Vice President, Investor Relations and Corporate Strategy

Telephone: (978) 787-2352

Email: David.Ryzhik@axcelis.com

 

Press/Media Relations Contact:

Maureen Hart

Senior Director, Corporate & Marketing Communications

Telephone: (978) 787-4266

Email: Maureen.Hart@axcelis.com

 

 


 

News Release  

 

Axcelis Technologies, Inc.

Consolidated Statements of Operations

(In thousands, except per share amounts)

(Unaudited)

 

    Three months ended     Nine months ended  
    September 30,     September 30,  
    2025     2024     2025     2024  
Revenue:                        
Product   $ 201,218     $ 246,826     $ 567,444     $ 735,626  
Services     12,393       9,738       33,274       29,822  
Total revenue     213,611       256,564       600,718       765,448  
Cost of revenue:                                
Product     112,078       136,379       302,041       399,049  
Services     12,727       10,215       33,761       27,968  
Total cost of revenue     124,805       146,594       335,802       427,017  
Gross profit     88,806       109,970       264,916       338,431  
Operating expenses:                                
Research and development     24,640       26,395       78,832       77,843  
Sales and marketing     15,838       16,808       45,965       51,483  
General and administrative     23,308       19,854       56,976       52,842  
Total operating expenses     63,786       63,057       181,773       182,168  
Income from operations     25,020       46,913       83,143       156,263  
Other income (expense):                                
Interest income     5,465       6,560       16,547       18,126  
Interest expense     (1,305 )     (1,333 )     (4,028 )     (4,017 )
Other, net     970       3,225       2,569       1,257  
Total other income     5,130       8,452       15,088       15,366  
Income before income taxes     30,150       55,365       98,231       171,629  
Income tax provision     4,164       6,789       12,290       20,593  
Net income   $ 25,986     $ 48,576     $ 85,941     $ 151,036  
Net income per share:                                
Basic   $ 0.83     $ 1.49     $ 2.70     $ 4.63  
Diluted   $ 0.83     $ 1.49     $ 2.70     $ 4.61  
Shares used in computing net income per share:                                
Basic weighted average shares of common stock     31,287       32,550       31,796       32,595  
Diluted weighted average shares of common stock     31,450       32,675       31,863       32,780  

 

 


 

News Release  

 

Axcelis Technologies, Inc.

Consolidated Balance Sheets

(In thousands, except per share amounts)

(Unaudited)

 

    September 30,     December 31,  
    2025     2024  
ASSETS
Current assets:                
Cash and cash equivalents   $ 187,501     $ 123,512  
Short-term investments     262,059       447,831  
Accounts receivable, net     147,636       203,149  
Inventories, net     324,342       282,225  
Prepaid income taxes     4,687       6,420  
Prepaid expenses and other current assets     57,804       60,471  
Total current assets     984,029       1,123,608  
Property, plant and equipment, net     57,979       53,784  
Operating lease assets     29,499       29,621  
Finance lease assets, net     14,440       15,346  
Long-term restricted cash     7,626       7,552  
Deferred income taxes     70,033       68,277  
Long-term investments     143,214       -  
Other assets     45,120       50,593  
Total assets   $ 1,351,940     $ 1,348,781  
LIABILITIES AND STOCKHOLDERS’ EQUITY                
Current liabilities:                
Accounts payable   $ 52,466     $ 46,928  
Accrued compensation     24,357       25,536  
Warranty     9,258       13,022  
Deferred revenue     81,486       94,673  
Current portion of finance lease obligation     1,505       1,345  
Other current liabilities     29,917       26,018  
Total current liabilities     198,989       207,522  
Long-term finance lease obligation     41,166       42,329  
Long-term deferred revenue     47,434       43,501  
Other long-term liabilities     44,207       42,639  
Total liabilities     331,796       335,991  
                 
Stockholders’ equity:                
Common stock, $0.001 par value, 75,000 shares authorized; 30,998 shares issued and outstanding at September 30, 2025; 32,365 shares issued and outstanding at December 31, 2024     31       32  
Additional paid-in capital     532,951       548,654  
Retained earnings     488,771       470,318  
Accumulated other comprehensive loss     (1,609 )     (6,214 )
Total stockholders’ equity     1,020,144       1,012,790  
Total liabilities and stockholders’ equity   $ 1,351,940     $ 1,348,781  

 

 


 

News Release  

 

Axcelis Technologies, Inc.

Condensed Consolidated Statements of Cash Flows

(In thousands)

(Unaudited)

 

    Three months ended     Nine months ended  
    September 30,     September 30,  
    2025     2024     2025     2024  
Cash flows from operating activities                                
Net income   $ 25,986     $ 48,576     $ 85,941     $ 151,036  
Adjustments to reconcile net income to net cash provided by operating activities:                                
Depreciation and amortization     4,328       3,906       13,152       11,542  
Stock-based compensation expense     5,344       5,412       15,668       15,571  
Other     6,907       (16,346 )     (4,110 )     (11,090 )
Change in other assets and liabilities, net     2,785       4,200       14,221       (39,021 )
Net cash provided by operating activities     45,350       45,748       124,872       128,038  
                                 
Cash flows from investing activities                                
Expenditures for property, plant and equipment and capitalized software     (2,015 )     (3,899 )     (8,960 )     (7,523 )
Other changes in investing activities, net     3,393       (52,654 )     46,194       (110,324 )
Net cash provided by (used in) investing activities     1,378       (56,553 )     37,234       (117,847 )
                                 
Cash flows from financing activities                                
Repurchase of common stock     (32,335 )     (15,363 )     (95,850 )     (45,358 )
Other changes from financing activities, net     (440 )     (630 )     (4,022 )     (11,291 )
Net cash used in financing activities     (32,775 )     (15,993 )     (99,872 )     (56,649 )
                                 
Effect of exchange rate changes on cash and cash equivalents     (106 )     1,700       1,829       (774 )
Net increase (decrease) in cash, cash equivalents and restricted cash     13,847       (25,098 )     64,063       (47,232 )
                                 
Cash, cash equivalents and restricted cash at beginning of period     181,280       151,817       131,064       173,951  
Cash, cash equivalents and restricted cash at end of period   $ 195,127     $ 126,719     $ 195,127     $ 126,719  

 

 


 

News Release  

 

Notes on Our Non-GAAP Financial Information

 

Management uses non-GAAP gross profit, gross margin, operating income, operating margin, income tax provision, net income, diluted earnings per share, and Adjusted EBITDA to evaluate the Company’s operating and financial performance and for planning purposes. Axcelis believes these measures enhance an overall understanding of its performance and investors’ ability to review the Company’s business from the same perspective as the Company’s management.

 

There are limitations in using non-GAAP financial measures because the non-GAAP financial measures are not prepared in accordance with GAAP, may be different from non-GAAP financial measures used by other companies, and may exclude certain items that may have a material impact upon our reported financial results. The presentation of this additional information is not meant to be considered in isolation or as a substitute for the directly comparable financial measures prepared in accordance with GAAP.

 

Totals presented may not sum and percentages may not recalculate using figures presented due to rounding.

 

 


 

News Release  

 

Axcelis Technologies, Inc.

Schedule Reconciling Selected Non-GAAP Financial Measures

(In thousands, except per share amounts)

 

    Three months ended September 30,     Nine months ended September 30,  
    2025     2024     2025     2024  
GAAP gross Profit   $ 88,806     $ 109,970     $ 264,916     $ 338,431  
Restructuring1     -       -       226       876  
Stock-based compensation     499       354       1,421       1,106  
Non-GAAP gross profit   $ 89,305     $ 110,324     $ 266,563     $ 340,413  
Non-GAAP gross margin     41.8 %     43.0 %     44.4 %     44.5 %
                                 
GAAP operating expense   $ 63,786     $ 63,057     $ 181,773     $ 182,168  
Transaction and integration3     (8,274 )     -       (8,274 )     -  
Bad debt expense     -       (3,443 )     -       (2,984 )
Restructuring1     (236 )     -       (1,130 )     (553 )
Stock-based compensation     (4,845 )     (5,058 )     (14,247 )     (14,465 )
Non-GAAP operating expense   $ 50,431     $ 54,556     $ 158,122     $ 164,166  
                                 
GAAP operating income   $ 25,020     $ 46,913     $ 83,143     $ 156,263  
Transaction and integration3     8,274       -       8,274       -  
Bad debt expense     -       3,443       -       2,984  
Restructuring1     236       -       1,356       1,429  
Stock-based compensation     5,344       5,412       15,668       15,571  
Non-GAAP operating income   $ 38,874     $ 55,768     $ 108,441     $ 176,247  
Non-GAAP operating margin     18.2 %     21.7 %     18.1 %     23.0 %
                                 
GAAP income tax provision   $ 4,164     $ 6,789     $ 12,290     $ 20,593  
Income tax effect of Non-GAAP adjustments2     1,940       1,240       3,542       2,798  
Non-GAAP income tax provision   $ 6,104     $ 8,029     $ 15,832     $ 23,391  
                                 
GAAP net income   $ 25,986     $ 48,576     $ 85,941     $ 151,036  
Transaction and integration3     8,274       -       8,274       -  
Bad debt expense     -       3,443       -       2,984  
Restructuring1     236       -       1,356       1,429  
Stock-based compensation     5,344       5,412       15,668       15,571  
Income tax effect of Non-GAAP adjustments2     (1,940 )     (1,240 )     (3,542 )     (2,798 )
Non-GAAP net income   $ 37,900     $ 56,191     $ 107,697     $ 168,222  
                                 
GAAP diluted EPS   $ 0.83     $ 1.49     $ 2.70     $ 4.61  
Transaction and integration3     0.26       -       0.26       -  
Bad debt expense     -       0.11       -       0.09  
Restructuring1     0.01       -       0.04       0.04  
Stock-based compensation     0.17       0.16       0.49       0.48  
Income tax effect of Non-GAAP adjustments2     (0.06 )     (0.04 )     (0.11 )     (0.09 )
Non-GAAP diluted EPS   $ 1.21     $ 1.72     $ 3.38     $ 5.13  

 

Note 1: Restructuring and other costs primarily related to early retirement programs and severance costs, due to global cost-saving initiatives.

Note 2: Impact of taxes from non-GAAP adjustments, uses adjusted tax rate of 14%.

Note 3: Transaction and integration costs include expenses associated with the merger agreement with Veeco Instruments, announced on October 1, 2025.

 

 


 

News Release  

 

Axcelis Technologies, Inc.

Reconciliation of Net Income to Adjusted EBITDA

(In thousands, except percentages)

 

    Three months ended September 30,     Nine months ended September 30,  
    2025     2024     2025     2024  
Net Income   $ 25,986     $ 48,576     $ 85,941     $ 151,036  
Other (income)/expense     (5,130 )     (8,452 )     (15,088 )     (15,366 )
Income tax provision     4,164       6,789       12,290       20,593  
Depreciation & amortization     4,328       3,906       13,152       11,542  
Subtotal     29,348       50,819       96,295       167,805  
Transaction and integration2     8,274       -       8,274       -  
Bad debt expense     -       3,443       -       2,984  
Restructuring1     236       -       1,356       1,429  
Stock-based compensation     5,344       5,412       15,668       15,571  
Adjusted EBITDA   $ 43,202     $ 59,674     $ 121,593     $ 187,789  
Adjusted EBITDA margin     20.2 %     23.3 %     20.2 %     24.5 %
                                 

 

Note 1: Restructuring and other costs primarily related to early retirement programs and severance costs, due to global cost-saving initiatives.

Note 2: Transaction and integration costs include expenses associated with the merger agreement with Veeco Instruments, announced on October 1, 2025.

 

 


 

News Release  

 

Axcelis Technologies, Inc.
Fourth Quarter Outlook
GAAP to Non-GAAP Diluted Earnings Per Share

 

    Three months ended
December 31, 2025
 
GAAP diluted EPS   $ 0.76  
Transaction and Integration2     0.19  
Restructuring3     0.05  
Stock-based compensation     0.18  
Income tax effect of non-GAAP adjustments1     (0.06 )
Non-GAAP diluted EPS   $ 1.12  

 

Note 1: Impact of taxes from non-GAAP adjustments, uses adjusted tax rate of 14%.

Note 2: Transaction and Integration costs include expenses associated with the merger agreement with Veeco Instruments, announced on October 1, 2025.

Note 3: Restructuring and other costs primarily related to early retirement programs and severance costs, due to global cost-saving initiatives.